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Wolframin, a transmembrane glycoprotein of endoplasmic reticulum consisting of 
890 amino acids, is encoded by the WFS1 gene, mutated in the Wolfram syndrome. 
This pathology, also called DIDMOAD, is an autosomal recessive disorder defi ned by 
the association of diabetes mellitus, optic atrophy, and further organ abnormalities.
To gain further insight into the pathogenesis of diseases associated with WFS1 
mutations, we conducted an immunohistochemical study to investigate its pattern of 
expression in human female reproductive tract in physiologic and pathologic condi-
tions. For this purpose, samples of physiologic and pathologic endometrium, sam-
ples of placenta throughout pregnancy in normal and diabetic pregnant women, were 
used. In physiologic endometrium, we observed a light increase of wolframin from 
proliferative to secretory phase where wolframin was localized in the glands, stroma 
and cells lining blood vessels. In menopause, wolframin expression increased with 
a glandular and stromal localization. In pathologic endometrium, we observed an 
increase of wolframin expression from hyperplasia to polyps until a higher expres-
sion in carcinoma tissues. In normal placenta there was a modulation of wolframin 
throughout pregnancy with a strong level of expression during the fi rst trimester and 
a moderate level in the third trimester. In diabetic women, the wolframin expres-
sion was strongly reduced in the third trimester of gestation. In human endometri-
um, wolframin seems to have a role in diff erentiation program. Deregulation of these 
functions may induce the onset of several endometrial pathologies. Moreover, in nor-
mal placenta wolframin may be required to sustain normal rates of cytotrophoblast 
cell proliferation during the fi rst trimester of gestation.
The decrease of wolframin expression in diabetic placentae may hypothesize that 
this protein is directly regulated by insulin concentration also in the placenta, sug-
gesting that this protein physiologically maintain the glucose homeostasis in this 
organ.
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